Free Energy Methods in Drug Discovery

Edited by:   Kira A. Armacost (Principal Investigator Principal Investigator GlaxoSmithKline Pharmaceuticals), David C. Thompson (Senior Applications Scientist, Senior Applications Scientist, Chemical Computing Group)
Imprint:   Oxford University Press Inc
Country of Publication:   United States
Dimensions:   Height: 261mm,  Width: 183mm,  Spine: 25mm
Weight:   900g
ISBN:   9780841298064
ISBN 10:   0841298068
Series:   ACS SYMPOSIUM SERIES
Pages:   310
Publication Date:   02 February 2023
Audience:   Professional and scholarly ,  Undergraduate
Format:   Hardback
Publisher's Status:   Active

Kira A. Armacost received her undergraduate degree in chemistry at the University of Tampa, Ph.D. from Auburn University, and performed postdoctoral research at the University of Michigan. The focus of her doctoral and postdoctoral research was using free energy calculations in organic chemistry and drug discovery. After her postdoctoral fellowship, she accepted a position at Merck & Co., Inc. working on drug discovery projects for multiple therapeutic areas. Kira recently transitioned to GlaxoSmithKline Pharmaceuticals in the Computational Sciences group performing research in drug discovery. Kira has been actively involved in the ACS, serving as an alternate councilor for ACS COMP, previously chaired the Journal of Chemical Information and Modeling's Early Career Board (2017-2020) and is now on the Editorial Advisory board for JCIM. She also participates in STEM initiatives for middle and high school students, is a co-organizer for the Women Make COMP symposium at ACS meetings and is a mentor for girls and women in computational chemistry. David C. Thompson has an undergraduate degree in Chemical Physics from University College London, and a Ph.D. in Theoretical Chemistry from the University of Cambridge. Following a post-doctoral fellowship focused on numerical methods in electronic structure, David transitioned into the pharmaceutical industry and spent many years providing computational support and solutions to drug discovery programs. David's research spans foundational quantum mechanics through open innovation, crowd sourcing, and novel methods of organizational learning. Currently at Chemical Computing Group (CCG), David is a member of the support team helping CCG customers translate their scientific problems into actionable solutions.